scispace - formally typeset
G

Giovanni Almadori

Researcher at Catholic University of the Sacred Heart

Publications -  114
Citations -  2614

Giovanni Almadori is an academic researcher from Catholic University of the Sacred Heart. The author has contributed to research in topics: Cancer & Laryngectomy. The author has an hindex of 29, co-authored 105 publications receiving 2372 citations. Previous affiliations of Giovanni Almadori include Agostino Gemelli University Polyclinic & The Catholic University of America.

Papers
More filters
Journal ArticleDOI

Postlaryngectomy Pharyngocutaneous Fistula: Incidence, Predisposing Factors, and Therapy

TL;DR: In presence of a specific risk factor, PCF can be expected; nevertheless, its prevention remains very difficult and the “wait and see” approach for 28 days before proceeding with a surgical approach is suggested.
Journal ArticleDOI

Molecular markers in laryngeal squamous cell carcinoma: Towards an integrated clinicobiological approach

TL;DR: To reduce laryngeal cancer-related mortality, a change in clinical approach is required and some of the most significant biological markers might be integrated with the evaluation of behavioural risk factors, clinical TNM staging and histopathological grading for a novel clinicomolecular approach.
Journal ArticleDOI

Percutaneous translaryngeal versus surgical tracheostomy: A randomized trial with 1-yr double-blind follow-up.

TL;DR: Compared with ST, the main advantages of TLT are that it is more rapid and associated with less postoperative bleeding, and Infectious complications, particularly postoperative bacteremia, and long-term effects are similar with the two procedures.
Journal ArticleDOI

The role of acid and alkaline reflux in laryngeal squamous cell carcinoma.

TL;DR: This work has shown that gastroesophageal reflux as independent carcinogenic factor and co‐carcinogen in association with smoking and alcohol assumption is viable and effective in patients with squamous cell carcinoma.
Journal Article

New insights into human papillomavirus-associated head and neck squamous cell carcinoma.

TL;DR: Treatment selection in HPV-related oropharyngeal carcinoma is becoming a critical issue, and although there is no evidence from randomized, controlled trials to support a treatment de-escalation inHPV-positive SCC, some investigators argue that intensive combined modality strategies may represent an overtreatment.